Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
R-Bos is a Japanese biotechnology company specializing in regenerative medicine and stem cell technologies. Spun out from research at Tohoku University, the company focuses on developing innovative cell-based therapies and providing specialized services for stem cell processing and regeneration. R-Bos aims to bridge the gap between academic research and clinical application by leveraging its proprietary platforms for cell culture and differentiation. The company's business model includes both internal drug discovery programs and partnerships with academic and industrial entities to advance the field of regenerative medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on R.Bos.